Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia
Richard J. Levine(National Institutes of Health), Diana W. Bianchi(Tufts Medical Center), Cong Qian(Allied Technology (United States)), Tuangsit Wataganara(Tufts University), Lucinda J. England(National Institutes of Health), Roberto Romero(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Kai Yu, Erik S LeShane(Tufts University), Enrique F. Schisterman(National Institutes of Health)
Cited by 240
Related Papers
Circulating Angiogenic Factors and the Risk of Preeclampsia
|New England Journal of Medicine|2004|3.6k
Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
|Epidemiology|2009|1.9k
The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic Curve
|American Journal of Epidemiology|2006|1.8k
Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection
|Biometrical Journal|2008|1.3k